Clinical Trial Update: Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522) [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating ezetimibe monotherapy for primary hypercholesterolemia has completed. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Zetia (ezetimibe)

Snippet

Sponsor: Organon and Co | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2013-05-30